Teicoplanin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Glycopeptide antibiotic.

Half-lifeThis section has been translated automatically.

3,5 h

Spectrum of actionThis section has been translated automatically.

Clostridium spp., Corynebacterium diphtheriae, Enterococcus spp., Staph. aureus, coagulase-negative staphylococci, Streptococcus spp.

IndicationThis section has been translated automatically.

Identical to vancomycin.

Limited indicationThis section has been translated automatically.

Breastfeeding.

Dosage and method of useThis section has been translated automatically.

  • Adults/teenagers: 200-800 mg/day i.v. depending on the severity of the infection
  • Children < 12 years. 3 times 10 mg/kg bw/day i.v.

ContraindicationThis section has been translated automatically.

Renal failure, pregnancy.

PreparationsThis section has been translated automatically.

Targocid

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer